Link N as a therapeutic agent for discogenic pain

Area of Science:

• Biochemistry and Molecular Biology
• Pain Research
• Regenerative Medicine

Background:

• Neurotrophins (NTs) drive sensory nerve sprouting and pain in degenerative disc disease.
• Intervertebral disc (IVD) cells express NTs, upregulated by inflammatory cytokines, leading to discogenic pain.
• Current therapies lack targeted approaches to reduce nerve ingrowth in degenerative disc disease.

Purpose of the Study:

• To investigate Link N's potential to suppress NTs and their receptors in the context of disc degeneration.
• To evaluate the effect of Link N on nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and their receptors TrkA and TrkB.
• To assess Link N's impact on substance P in cytokine-stimulated human annulus fibrosus (AF) cells.

Main Methods:

• Human AF cells from normal IVDs were stimulated with interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α).
• Cells were treated with or without Link N peptide.
• NGF protein levels were measured by Western blotting; gene expression of NGF, BDNF, TrkA, and TrkB was quantified using real-time PCR.

Main Results:

• Link N significantly decreased gene expression of NGF, BDNF, TrkA, and TrkB in cytokine-stimulated AF cells.
• Link N suppressed NGF protein release in IL-1β-stimulated AF cells.
• Link N demonstrated an ability to counteract inflammatory upregulation of key pain mediators in AF cells.

Conclusions:

• Link N effectively suppresses the stimulation of NGF, BDNF, and their receptors in an inflammatory environment within AF cells.
• These findings suggest Link N has therapeutic potential for both repairing early-stage disc degeneration and alleviating associated pain.
• Link N may offer a targeted approach to managing discogenic pain by reducing neurotrophin-mediated hyperinnervation.